 
                    
                JW SHINYAK CORPORATION
Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.
067290 | KO
Overview
Corporate Details
- ISIN(s):
- KR7067290007
- LEI:
- Country:
- South Korea
- Address:
- 경기도 과천시 과천대로7길 38 -, 과천시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
JW Shinyak Corporation is a pharmaceutical company that operates as a specialized maker for the clinical market. The company develops, produces, and supplies high-quality specialty medicines and medical supplies, with a primary focus on the fields of dermatology, urology, and otolaryngology. Committed to research and development, JW Shinyak aims to develop innovative new drugs through advanced medical technology, including its proprietary "DC vacuum technology" and "CTP". The company's product portfolio includes treatments for conditions such as androgenic alopecia (hair loss), endocrine disorders, and various bacterial infections.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 1.1 MB | ||
| 2025-08-01 00:00 | Earnings Release 영업(잠정)실적(공정공시)               | Korean | 14.2 KB | ||
| 2025-05-15 00:00 | Quarterly Report 분기보고서 (2025.03) | Korean | 1015.4 KB | ||
| 2025-05-08 00:00 | Earnings Release 영업(잠정)실적(공정공시)               | Korean | 14.2 KB | ||
| 2025-03-26 00:00 | Post-Annual General Meeting Information 정기주주총회결과               | Korean | 22.7 KB | ||
| 2025-03-19 00:00 | Annual Report [기재정정]사업보고서 (2024.12) | Korean | 1.7 MB | ||
| 2025-03-18 00:00 | Audit Report / Information 사업보고서 (2024.12) | Korean | 474.4 KB | ||
| 2025-03-14 00:00 | Audit Report / Information 감사보고서제출               | Korean | 25.9 KB | ||
| 2025-02-25 00:00 | Earnings Release [기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동               | Korean | 18.2 KB | ||
| 2025-02-25 00:00 | Pre-Annual General Meeting Information 주주총회소집공고 | Korean | 95.3 KB | ||
| 2025-02-25 00:00 | Proxy Solicitation & Information Statement 의결권대리행사권유참고서류 | Korean | 96.4 KB | ||
| 2025-02-10 00:00 | Pre-Annual General Meeting Information 주주총회소집결의               | Korean | 12.4 KB | ||
| 2025-02-07 00:00 | Regulatory News Service 주식등의대량보유상황보고서(일반) | Korean | 74.0 KB | ||
| 2025-02-07 00:00 | Regulatory News Service 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 22.2 KB | ||
| 2025-02-07 00:00 | Regulatory News Service 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 21.4 KB | 
Automate Your Workflow. Get a real-time feed of all JW SHINYAK CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for JW SHINYAK CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for JW SHINYAK CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    